Status:

UNKNOWN

Predictive Analytics and Peer-Driven Intervention for Guideline-based Care for Sleep Apnea

Lead Sponsor:

University of Arizona

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Obstructive Sleep Apnea

Eligibility:

All Genders

21-85 years

Phase:

NA

Brief Summary

Obstructive sleep apnea (OSA) is a prevalent condition that affects 7 to 12% of the US population and is characterized by repetitive collapse of the upper airway during sleep. Continuous positive airw...

Detailed Description

OSA affects 7 to 12% of the US population and is an independent risk factor for several clinical consequences such as systemic hypertension, cardiovascular disease, stroke, reduced HR-QOL, increased a...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for Subject:
  • Referral for sleep study testing for possible OSA
  • Medicaid and dual-eligible Medicare beneficiaries
  • Household income in the bottom national quartile of household median income
  • Inclusion Criteria for Peer Buddy:
  • Adherent to CPAP therapy (greater than or equal to 4 hours per night of CPAP use)
  • Willing to meet with peer-buddy on 2-4 occasions in-person
  • Has a cell phone or other reliable telephone line
  • Willing to undergo one-two training and orientation session(s) and pass a subsequent mock patient interaction
  • Exclusion Criteria for Subject:
  • Central sleep apnea (CSA)
  • Participation in another intervention-based research study
  • Patient's primary care provider refuses patient participation for medical instability
  • Exclusion Criteria for Peer Buddy:
  • Central sleep apnea (CSA)
  • Participation in another intervention-based research study
  • Patient's primary care provider refuses patient participation for medical instability
  • Major depression or other major psychiatric illness
  • Shift-worker or frequent out of town traveler

Exclusion

    Key Trial Info

    Start Date :

    November 17 2017

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    October 11 2018

    Estimated Enrollment :

    145 Patients enrolled

    Trial Details

    Trial ID

    NCT03345524

    Start Date

    November 17 2017

    End Date

    October 11 2018

    Last Update

    November 17 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Arizona

    Tucson, Arizona, United States, 85721